Agios stock drops as mitapivat's Phase 3 trial shows strong hemoglobin gains but limited impact on sickle cell pain crises, ...

Trial met primary endpoint of hemoglobin response and key secondary endpoints of change from baseline in hemoglobin concentration and indirect ...

“Komzifti provides a new treatment option for adults with relapsed or refractory AML who have limited treatment options,” said Benito Fernandez, Chief Commercial Officer. “We are proud to partner with ...

Detailed price information for Bayer Aktienges ADR (BAYRY) from The Globe and Mail including charting and trades.

The patient who was hospitalized after receiving Intellia Therapeutics’ CRISPR therapy nex-z has died. | The patient who was ...

"Komzifti provides a new treatment option for adults with relapsed or refractory AML who have limited treatment options," said Benito Fernandez, Chief Commercial Officer. "We are proud to partner with ...

Meredith Roberts, a 17-year-old senior at North Tonawanda High School is in need of a liver transplant. A living donor, with ...

Vitamin B12 deficiency develops slowly but can cause lasting damage if untreated. Warning signs include fatigue, tingling hands or feet, a red tongue and memory issues. Boost your intake with vitamin ...

A patient with transthyretin amyloidosis (ATTR) who received the investigational gene therapy nexiguran ziclumeran (nex-z) in ...

While every soon-to-be parent hopes for a smooth, uneventful pregnancy, labor, and delivery, birth trauma and injury can be ...

Intellia Therapeutics has acknowledged the death of the elderly patient hospitalized last week in its Phase III trial of assessing nexiguran ziclumeran (nex-z) in transthyretin amyloidosis with ...